-
A Collection of Pharma Sources Insight 2020, Open to Review on the Pharma Industry 2020
PharmaSources.com
November 17, 2020
Now, let's have a review on the three issues of Pharma Sources Insight in 2020 and stay tuned with PharmaSources.com for the updated news on the pharmaceutical industry.
-
With Up to 18 First Generics, Hansoh Ranking Second in the Industry in China
PharmaSources/Caicai
November 16, 2020
China’s pharmaceutical industry has started to shift from “sales-driven” to “R&D-driven” since the drug review reform in 2015.
-
Inactivated Virus Vaccines vs. mRNA Vaccines: Differences between China and the U.S. in Preferred Technologies for Developing COVID-19 Vaccines
PharmaSources/Xiaoyaowan
November 13, 2020
The cumulative number of confirmed cases of COVID-19 has exceeded 11.30 million worldwide by July 5. The vaccine development has been in full swing in each country since the occurrence of the virus.
-
Which Will Go Further? Innovent or Junshi?
PharmaSources/Caicai
November 10, 2020
Junshi Biosciences was officially listed on the SSE STAR Market on July 15, with the stock code: 688180 and the issue price at RMB55.5/share; the opening price surged by nearly 200%, with the market value peaking at more than RMB150 billion.
-
A Review of the Great Journey of Capecitabine that Has Been Marketed in China for 20 Years
PharmaSources/Wang Hong
November 10, 2020
Fluorouracil has been used in clinical treatment for more than half a century. Capecitabine, an oral prodrug of fluorouracil, is very convenient to use and is one of the classical chemotherapeutics widely used in clinical practice.
-
The Layout of Inhalation Formulations in the Chinese Market (I)
PharmaSources/zhulikou431
June 24, 2020
Inhalation formulations are a dosage form with high technical barriers, with relatively few pharmaceutical enterprises entering this field at the beginning.
-
Medical C B D Oil Side Effects and Drug Interactions
PharmaSources/Keith J. Myers
October 20, 2020
Cannabidiol (CBD) has gained immense popularity for its ability to deal with various health conditions such as anxiety, insomnia, and chronic pain.
-
Does C B D Oil Really Bring Good Results for Depression
PharmaSources/Keith J. Myers
October 14, 2020
More and more people are using C B D or cannabidiol products to aid in their recovery from depression. And though there is a lack of clinical trials, there is a substantial number of studies that show that C B D could help in recovering from depression.
-
This Japanese Enterprise Refused the Inspection of the Chinese Drug Regulator
PharmaSources/Laoxue
September 23, 2020
The Japanese pharmaceutical enterprise: Sanyo Chemical Laboratories Co., Ltd.’s refusal of the NMPA’s inspection was disclosed and exposed by the NMPA on July 31.
-
Pharmaceutical News of August | PharmaSources.com: COVID-19
PharmaSources/Caicai
September 23, 2020
AstraZeneca announced the initiation of Phase III clinical trial for its adenovirus vector-based COVID-19 vaccine: AZD1222 in the U.S. on Aug. 31, which has a code of D8110C00001 and is funded by the Biomedical Advanced Research and Development Authority